Pharmacodynamics of Glyburide, Metformin, and Glyburide/Metformin Combination Therapy in the Treatment of Gestational Diabetes Mellitus
- 25 January 2020
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 107 (6), 1362-1372
- https://doi.org/10.1002/cpt.1749
Abstract
In gestational diabetes mellitus (GDM), women are unable to compensate for the increased insulin resistance during pregnancy. Data are limited regarding the pharmacodynamic effects of metformin and glyburide during pregnancy. This study characterized insulin sensitivity (SI), β‐cell responsivity, and disposition index (DI) in women with GDM utilizing a mixed‐meal tolerance test (MMTT) before and during treatment with GLY monotherapy (GLY, n=38), metformin monotherapy (MET, n=34), or glyburide and metformin combination therapy (COMBO; n=36). GLY significantly decreased dynamic β‐cell responsivity (31%). MET and COMBO significantly increased SI (121% and 83%, respectively). While GLY, MET, and COMBO improved DI, metformin (MET and COMBO) demonstrated a larger increase in DI (p=0.05) and a larger decrease in MMTT peak glucose concentrations (p=0.03) than subjects taking only GLY. Maximizing SI with MET followed by increasing β‐cell responsivity with GLY or supplementing with insulin might be a more optimal strategy for GDM management than monotherapy.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U10HD063094, U10HD047892, U10HD097905, U10HD047891, U10HD057753)
- National Institute of General Medical Sciences (R01GM124264)
- University of Washington
This publication has 53 references indexed in Scilit:
- Functional characterization of MATE2-K genetic variants and their effects on metformin pharmacokineticsPharmacogenetics and Genomics, 2013
- A Common 5′-UTR Variant in MATE2-K Is Associated With Poor Response to MetforminClinical Pharmacology & Therapeutics, 2011
- Pharmacokinetics of Metformin during PregnancyDrug Metabolism and Disposition, 2010
- Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metforminPharmacogenetics and Genomics, 2009
- Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical PracticeClinical Pharmacology & Therapeutics, 2009
- Assessment of β-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose testsAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organizationAmerican Journal of Obstetrics and Gynecology, 2005
- Glyburide for the treatment of gestational diabetesAmerican Journal of Obstetrics and Gynecology, 2004
- The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) StudyInternational Journal of Gynecology & Obstetrics, 2002
- Insulin Sensitivity from Meal Tolerance Tests in Normal Subjects: A Minimal Model IndexJournal of Clinical Endocrinology & Metabolism, 2000